J.F.R. Robertson

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

Anthony Howell, D.J. DeFriend, R.W. Blamey et al. · The Lancet · 1995 · 348 citations

Breast Oncology, Oncology, Tamoxifen-resistant Breast Cancer +10

Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer.

J.F.R. Robertson, Robert I. Nicholson, NJ Bundred et al. · PubMed · 2001 · 216 citations

Breast Oncology, Versus Tamoxifen, Gynecology +16

Screening interval breast cancers: mammographic features and prognosis factors.

H.C. Burrell, D.M. Sibbering, A.R.M. Wilson et al. · Radiology · 1996 · 193 citations

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma

H. Pereira, S Pinder, D.M. Sibbering et al. · Histopathology · 1995 · 177 citations